BASi Opens New Office In Europe
BASI OPENS NEW OFFICE IN EUROPE TO BETTER SERVE
PHARMACEUTICAL AND BIOTECH COMPANIES
(WARWICKSHIRE, UK — November 12, 2008) — BASi <http://www.basinc.com/> , a leading provider of contract laboratory services and manufacturer of scientific instruments in the US, has announced the opening of its new European laboratory and office in Warwickshire, UK. The relocation to a new, upgraded facility with expanded labs provides clients with enhanced capabilities throughout Europe.
Like its North American counterparts, the new 10,000 square foot facility offers a comprehensive bioanalytical capability, as well as providing access to the BASi Group’s full range of preclinical and pharmaceutical analysis services for pharmaceutical and biotechnology companies. BASi Europe also distributes the complete line of BASi instruments and equipment, as well as providing support for customers and distributors throughout Europe.
“BASi Europe offers over a thousand established and validated analytical methods and procedures,” said Mark Wareing, managing director of BASi Europe. “We currently have multiple industry standard LC-MS/MS stations as well as LC-EC and other analytical technologies, and we are investing in two more high-sensitivity MS/MS instruments with state-of-the-art front-end analytical systems. We offer complete peace of mind with an enviable track record of delivering internationally compliant GLP/GCP regulated studies.”
Visit with Mark Wareing, BASi Europe managing director, and other BASi representatives at the upcoming AAPS Annual Meeting and Exhibition, November 16-20, Atlanta, GA. Stop by booth #1016.
About BASi
BASi provides contract research services and specialized instrumentation and accessories for electrochemistry and in vivo sampling products to the world’s leading drug development companies. The company focuses on developing innovative services and products that increase efficiency and reduce the cost of taking new drugs to market. Visit www.BASInc.com <http://www.basinc.com/> for more information about BASi.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
